|
|
|
Pharmaceutical Manufacturing and Packing Sourcer
|
Are the right patients receiving the right drugs in the right dosage at the right time? Preventing medication errors is high on the agenda not only of hospitals, but the pharmaceutical wholesalers, the pharmaceutical industry and also governments worldwide. The American health care sector is focusing on minimising errors in administering medication. By scanning medication at the patient's bedside, errors can be reduced by as much as 50 per cent or more according to the Federal Drug Administration (FDA). It is no wonder therefore that in mid-2003, the FDA ruled that there should be bar codes on each unit dose. Much research is carried out in order to calculate the percentage of medication errors occurring. Just about every country worldwide has done at least one research project on this subject.
Depending on which research report you read (and depending on the definition of medication error used) the percentage of medication errors varies between 10 and 25 per cent. Almost 0.5 per cent result in permanent injury and 0.25 per cent of patients die due to the wrong medicine or wrong dosage being administered. Although it looks like a small percentage in relation to the size of the population, this number is unacceptable. In addition, the costs of recovery, such as the expense of contra-medication and an extra stay in hospital, are estimated to be an annual ˆ300 million in countries such as The Netherlands. These figures are worrying, especially if you have ever been a patient, and solutions must be found.
|
Read full article from PDF >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
Industry Events |
 |
BioPharm America™ 2012
19-21 September 2012, Westin Boston Waterfront, Boston, MA
Where partnerships start
Beginning its fifth year as an
industry event, BioPharm America
creates a robust exchange among hundreds of executives from venture capital
firms, major pharmaceutical companies, academic institutions and biotechnology
companies of every size from mature to start-up.
More info >> |
|
 |
News and Press Releases |
 |
GE Healthcare and Refine Technology sign supply and distribution agreement to support drive for continuous processing in biopharmaceutical manufacture
GE Healthcare, the healthcare business of GE (NYSE: GE) has signed a worldwide supply and distribution agreement with Refine Technology, a manufacturer and supplier of novel filtration systems for use in biopharmaceutical manufacturing. Under the terms of the agreement, GE Healthcare will supply Refine Technology with its innovative hollow fiber filtration cartridges for use with Refine Technology’s ATF™ system.
More info >> |
|
|
